Biotech’s Slaughter Continues

The year's best-performing sector fell into negative territory in just over a week. More 

Wall Street Hit as the Dow Jones Tests 16,000

Stocks are still in the midst of their "hike or no hike" anxiety attack, while the weakness is backed up by government action against Big Pharma and disappointing economic data from China, sending the Dow Jones lower. More 

Politics, Price Gouging and Healthcare Potential (REGN, IBB, BIIB)

We saw a wave of selling in biotech stocks during the week, but here's why I'm still bullish on healthcare, and biotech in particular. More 

Stocks Move Lower on Continued Weakness in Biotech

Financials were the winners of the day, while the selloff in biotech pressured all indices but the Dow Jones, which Nike (NKE) propped up on strong earnings. More 

Did Hillary Clinton Make Biotech Stocks a Bargain?

Hillary Clinton's tweets on the commotion surrounding Martin Shkreli and price gouging has made biotech stocks an opportunity right now. More 

Biotech Stocks: Is It Safe to Come out Now? (IBB, XBI)

Biotech stocks are getting smashed this week, but betting against the sector remains a bad idea. The only trick is getting the timing right. More 

Biotech on Sale, Get Ready to Buy

A breakdown could result in a 20% discount on many top biotech stocks. More